1. |
赵培泉,费萍. 早产儿视网膜病变诊断治疗研究现状、问题及展望[J].中华眼底病杂志,2012, 28:3-7.
|
2. |
Kuhrt H, Gryga M, Wolburg H, et al. Postnatal mammalian retinal development:quantitative data and general rules[J]. Prog Retin Eye Res, 2012, 31:605-621.
|
3. |
Ranchod TM, Capone A Jr. Tips and tricks in pediatric vitreoretinal surgery[J]. Int Ophthalmol Clin, 2011, 51:173-183.
|
4. |
Lin KL, Hirose T, Kroll AJ, et al. Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition[J]. Semin Ophthalmol, 2009, 24:70-76.
|
5. |
Kriss A, Jeffrey B, Taylor D. The electroretinogram in infants and young children[J]. J Clin Neurophysiol, 1992, 9:373-393.
|
6. |
Hussein MA, Coats DK, Paysse EA. Use of the RetCam 120 for fundus evaluation in uncooperative children[J]. Am J Ophthalmol, 2004, 137:354-355.
|
7. |
Young B, Eggenberger E, Kaufman D. Current electrophysiology in ophthalmology:a review[J]. Curr Opin Ophthalmol, 2012, 23:497-505.
|
8. |
El-Dairi MA, Asrani SG, Enyedi LB, et al. Optical coherence tomography in the eyes of normal children[J]. Arch Ophthalmol, 2009, 127:50-58.
|
9. |
Kang KB, Wessel MM, Tong J, et al. Ultra-widefield imaging for the management of pediatric retinal diseases[J]. J Pediatr Ophthalmol Strabismus, 2013, 50:282-288.
|
10. |
Verdina T, Tsang SH, Greenstein VC, et al. Functional analysis of retinal flecks in Stargardt disease[J/OL]. J Clin Exp Ophthalmol, 2012,3:E1[2012-07-30]. http://www.ncbi.nlm.nih.gov/pubmed/24409374.
|
11. |
Fakin A, Jarc-Vidmar M, Glavac D, et al. Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2[J]. Vis Res, 2012, 75:60-70.
|
12. |
Xu Y, Zhou X, Zhang Q, et al. Screening for retinopathy of prematurity in China:a neonatal units-based prospective study[J]. Invest Ophthalmol Vis Sci, 2013, 54:8229-8236.
|
13. |
许迅. 规范眼底影像检查数据采集、评估行为,提升眼底影像检查诊断技术应用水平[J]. 中华眼底病杂志, 2013, 29:449-452.
|
14. |
张清炯. 加强眼底病基因研究,为防盲致盲作出更大贡献[J]. 中华眼底病杂志, 2011, 27:405-407.
|
15. |
杨文杰,张琦,赵培泉. 家族性渗出性玻璃体视网膜病变致病基因及信号传导途径[J]. 中华眼底病杂志, 2011, 27:497-499.
|
16. |
张勤,张琦,赵培泉. NDP基因相关视网膜病变研究[J]. 临床儿科杂志, 2013, 31:481-483.
|
17. |
Al-Saikhan FI. The gene therapy revolution in ophthalmology[J]. Saudi J Ophthalmol, 2013, 27:107-111.
|
18. |
Binley K, Widdowson P, Loader J, et al. Transduction of photoreceptors with equine infectious anemia virus vectors:safety and biodistribution of StarGen for Stargardt disease[J]. Invest Ophthalmol Vis, 2013, 54:4061-4071.
|
19. |
Pang JJ, Deng WT, Dai X, et al. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia[J/OL]. PLoS One, 2012, 7:E35250[2012-04-11].http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0035250.
|
20. |
Hufnagel RB, Ahmed ZM, Corrêa ZM, et al. Gene therapy for Leber congenital amaurosis:advances and future directions[J]. Graefe's Arch Clin Exp Ophthalmol, 2012, 250:1117-1128.
|
21. |
Ventrice P, Leporini C, Aloe JF, et al. Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases[J]. J Pharmacol Pharmacother, 2013, 4:38-42.
|
22. |
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, D'Amico DJ, Masonson HN, et al. Pegaptanib sodium for neovascular age-related macular degeneration:two-year safety results of the two prospective, multicenter, controlled clinical trials[J]. Ophthalmology, 2006, 113:992-1001.
|
23. |
Fleck BW. Management of retinopathy of prematurity[J]. Arch Dis Child Fetal Neonatal Ed, 2013, 98:454-456.
|
24. |
Mintz-Hittner HA, Best LM. Antivascular endothelial growth factor for retinopathy of prematurity[J]. Curr Opin Pediatr, 2009, 21:182-187.
|
25. |
Autrata R, Krejcírová I, Senková K, et al. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone Ⅰ and posterior zone Ⅱ[J]. Eur J Ophthalmol, 2012, 22:687-694.
|
26. |
Uparkar M, Sen P, Rawal A, et al. Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity:a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone[J]. Int Ophthalmol, 2011, 31:3-8.
|
27. |
Ray R, Barañano DE, Hubbard GB. Treatment of Coats' disease with intravitreal bevacizumab[J]. Br J Ophthalmol, 2013, 97:272-277.
|
28. |
Ramasubramanian A, Shields CL. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction[J]. Br J Ophthalmol, 2012, 96:356-359.
|
29. |
He YG, Wang H, Zhao B, et al. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab[J]. Graefe's Arch Clin Exp Ophthalmol, 2010, 248:1519-1521.
|
30. |
Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung[J]. Am J Physiol Lung Cell Mol Physiol, 2006, 290:209-221.
|
31. |
Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicentre trial for cryotherapy for retinopathy of prematurity:preliminary results[J]. Arch Ophthalmol, 1988, 106:471-479.
|
32. |
STOP-ROP Multicentre Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial Ⅰ:preliminary outcomes[J]. Pediatrics, 2000, 105:295-310.
|
33. |
Good WV, Early Treatment of Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment of Retinopathy of Prematurity (ETROP) randomized trial[J]. Trans Am Ophthalmol Soc, 2004, 102:233-248.
|
34. |
唐仕波,余洪华,李涛. 努力推动我国玻璃体视网膜手术的创新发展[J]. 中华眼底病杂志, 2012, 28:109-112.
|
35. |
Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments[J]. Ophthalmology, 2001, 108:2068-2070.
|
36. |
Kay CN, Quiram PH, Mahajan VB. 23-gauge pediatric vitrectomy using limbus-based trocar-cannulas[J]. Retina, 2012, 32:1023-1027.
|
37. |
Thompson JT. Advantages and limitations of small gauge vitrectomy[J]. Surv Ophthalmol, 2011, 56:162-172.
|
38. |
Azuma N, Ito M, Yokoi T, et al. Visual outcomes after early vitreous surgery for aggressive posterior retinopathy of prematurity[J]. JAMA Ophthalmol, 2013, 131:1309-1313.
|
39. |
Azuma N, Ishikawa K, Hama Y, et al. Early vitreous surgery for aggressive posterior retinopathy of prematurity[J]. Am J Ophthalmol, 2006, 142:636-643.
|
40. |
Xu Y, Zhang Q, Kang X, et al. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection[J]. Acta Ophthalmol, 2013, 91:304-310.
|
41. |
Yu H, Li T, Luo Y, et al. Long-term outcomes of vitrectomy for progressive X-linked retinoschisis[J]. Am J Ophthalmol, 2012, 154:394-402.
|
42. |
Shukla D, Singh J, Sudheer G, et al. Familial exudative vitreoretinopathy (FEVR):clinical profile and management[J]. Indian J Ophthalmol, 2003, 51:323-328.
|
43. |
Fei P, Zhang Q, Li J, et al. Clinical characteristics and treatment of 22 eyes of morning glory syndrome associated with persistent hyperplastic primary vitreous[J]. Br J Ophthalmol, 2013, 97:1262-1267.
|
44. |
Muftuoglu G, Gulkilik G. Pars plana vitrectomy in advanced Coats' disease[J]. Case Rep Ophthalmol, 2011, 2:15-22.
|
45. |
Wong SC, Capone A Jr. Microplasmin (ocriplasmin) in pediatric vitreoretinal surgery:update and review[J]. Retina, 2013, 33:339-348.
|
46. |
Ramsden CM, Powner MB, Carr AJ, et al. Stem cells in retinal regeneration:past, present and future[J]. Development, 2013, 140:2576-2585.
|
47. |
Tibbetts MD, Samuel MA, Chang TS, et al. Stem cell therapy for retinal disease[J]. Curr Opin Ophthalmol, 2012, 23:226-234.
|
48. |
李家恺,赵培泉.玻璃体手术治疗晚期早产儿视网膜病变的疗效及影响因素评估[J]. 中华眼底病杂志, 2012, 28:22-25.
|